Cigarette Smoking and Erectile Dysfunction: Focus on NO Bioavailability and ROS Generation
- 1 June 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 5 (6) , 1284-1295
Abstract
Thirty million men in the United States suffer from erectile dysfunction (ED) and this number is expected to double by 2025. Considered a major public health problem, which seriously affects the quality of life of patients and their partners, ED becomes increasingly prevalent with age and chronic smoking is a major risk factor in the development of ED. To review available evidence concerning the effects of cigarette smoking on vascular changes associated with decreased nitric oxide (NO) bioavailability and increased reactive oxygen species (ROS) generation. We examined epidemiological and clinical data linking cigarette smoking and ED, and the effects of smoking on vascular NO bioavailability and ROS generation. There are strong parallels between smoking and ED and considerable evidence supporting the concept that smoking-related ED is associated with reduced bioavailability of NO because of increased ROS. Cigarette smoking-induced ED in human and animal models is associated with impaired arterial flow to the penis or acute vasospasm of the penile arteries. Long-term smoking produces detrimental effects on the vascular endothelium and peripheral nerves and also causes ultrastructural damage to the corporal tissue, all considered to play a role in chronic smoking-induced ED. Clinical and basic science studies provide strong indirect evidence that smoking may affect penile erection by the impairment of endothelium-dependent smooth muscle relaxation or more specifically by affecting NO production via increased ROS generation. Whether nicotine or other products of cigarette smoke mediate all effects related to vascular damage is still unknown. Smoking prevention represents an important approach for reducing the risk of ED. The characterization of the components of cigarette smoke leading to ED and the mechanisms by which these components alter signaling pathways activated in erectile responses are necessary for a complete comprehension of cigarette smoking-associated ED. Tostes RS, Carneiro FS, Lee AJ, Giachini FRC, Leite R, Osawa Y, and Clinton Webb R. Cigarette smoking and erectile dysfunction: Focus on NO bioavailability and ROS generation.Keywords
Funding Information
- National Institutes of Health (HL71138, HL74167)
- National Institute on Drug Abuse (NIH (DA22354-01))
This publication has 111 references indexed in Scilit:
- Acute Effects of Nicotine on Physiological and Subjective Sexual Arousal in Nonsmoking Men: A Randomized, Double-Blind, Placebo-Controlled TrialThe Journal of Sexual Medicine, 2008
- Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) SurveyEuropean Urology, 2007
- Roles of Rho-Associated Kinase and Oxidative Stress in the Pathogenesis of Aortic StiffnessJACC, 2007
- Effect of cigarette smoking on nitric oxide, structural, and mechanical properties of mouse arteriesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunctionBiochemical and Biophysical Research Communications, 2006
- The effect of chronic tobacco smoking on arterial stiffnessBritish Journal of Clinical Pharmacology, 2006
- Smoking and other lifestyle factors in relation to erectile dysfunctionBJU International, 2005
- Reactive oxygen species in vascular biology: implications in hypertensionHistochemistry and Cell Biology, 2004
- The pathophysiology of cigarette smoking and cardiovascular diseaseJACC, 2004
- Neurotransmission and the contraction and relaxation of penile erectile tissuesWorld Journal of Urology, 1997